Observational studyAnaesthesia2026
Platelet function in patients undergoing major non-cardiac vascular surgery (PLUGS): a prospective cohort study.
Observational study in Anaesthesia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionPatients who require major vascular surgery often receive antiplatelet therapy for primary or secondary prevention of cardiovascular disease. Clopidogrel resistance and variability in platelet recovery after drug discontinuation pose clinical challenges, particularly for regional anaesthesia and blood management. The aim of this study was to characterise platelet function and determine the prevalence of antiplatelet resistance using near-patient viscoelastic testing in patients undergoing major, elective non-cardiac vascular surgery.
methodsWe conducted a single-centre, prospective, observational cohort study at a tertiary vascular surgery centre. Adults scheduled for elective vascular surgery were recruited into four groups: aspirin; clopidogrel; dual antiplatelet therapy; and control (no antiplatelet therapy). Blood samples were obtained at pre-operative assessment and on the day of surgery. Platelet function was assessed using thromboelastography and von Willebrand factor antigen levels. The primary outcome was the proportion of patients with antiplatelet resistance.
resultsEighty patients were enrolled, of whom 64 proceeded to surgery. Antiplatelet resistance was common, affecting 25-70% of patients at baseline depending on regimen and 15-83% on the day of surgery. Clopidogrel resistance was most frequent (70%). Two patients experienced early graft or stent thrombosis, both with evidence of clopidogrel resistance and elevated von Willebrand factor; von Willebrand factor levels exceeded the normal range in two-thirds of patients. In an exploratory analysis, clopidogrel cessation 5-7 days pre-operatively did not result in a statistically significant change in platelet inhibition. DISCUSSION: High rates of clopidogrel resistance and elevated von Willebrand factor were observed in patients with planned vascular surgery, suggesting that current peri-operative discontinuation guidelines may not restore normal platelet function. Larger multicentre studies that incorporate standardised platelet and near-patient genetic testing are required to validate these findings and guide personalised peri-operative antiplatelet management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.